Dr. Manisha Balwani is an Associate Professor in the Department of Genetics and Genomic Sciences and Medicine of the Icahn School of Medicine at Mount Sinai and Director of the Comprehensive Porphyria Diagnostic and Treatment Center at Mount Sinai. She is an investigator for NIH supported Rare Diseases Clinical Research Network’s Porphyrias Consortium and is the principal investigator on natural history studies and interventional clinical trials for Porphyria.
Dr. Balwani began her medical training at the University of Bombay, followed by a Master’s in Genetics at the University of Pittsburgh’s Graduate School of Public Health. She completed her Residency in Internal Medicine at North Shore University Hospital at Forest Hills followed by Fellowships in Medical Genetics and Clinical Biochemical Genetics at Mount Sinai Hospital. She joined the faculty of the Department of Genetics and Genomic Sciences at the Mount Sinai School of Medicine in 2006.
Her current research efforts focus on the acute and cutaneous Porphyrias, particularly defining disease severity, genotype-phenotype correlations and natural history. She is the principal investigator for clinical trials for new therapeutics for acute and cutaneous Porphyrias. She also serves as the Associate Administrative Director of the Porphyrias Consortium. She has published over 60 peer-reviewed articles and book chapters, and has presented her work at scientific conferences nationally and internationally.